Published in Ann Med Exp Biol Fenn on January 01, 1968
Viral hepatitis and tests for the Australia (hepatitis-associated) antigen and antibody. Bull World Health Organ (1970) 2.05
Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro. Clin Exp Immunol (1971) 1.60
Evidence for circulating immune complexes in sarcoidosis. Clin Exp Immunol (1974) 1.59
Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction. Clin Exp Immunol (1969) 1.38
Immunological aspects of leprosy with special reference to autoimmune diseases. Bull World Health Organ (1969) 1.14
Measles virus antibody in cerebrospinal fluids from patients with multiple sclerosis. Br Med J (1972) 0.98
Raynaud's disease. Arch Dis Child (1985) 0.98
Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br Med J (Clin Res Ed) (1985) 0.94
Circulating complexes in leprosy studied by the platelet aggregation test. The platelet aggregation test and its relation to the Rubino test and other sero-immunological parameters in 135 patients with leprosy. Clin Exp Immunol (1978) 0.91
Neutropenia in rheumatoid arthritis: studies on possible contributing factors. Ann Rheum Dis (1982) 0.86
Platelet aggregation by isolated and aggregated human IgG. Clin Exp Immunol (1975) 0.83
Subacute sclerosing panencephalitis as a cause of chronic dementia and relapsing brain disorder. J Neurol Neurosurg Psychiatry (1972) 0.82
Platelet-aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus. Clin Exp Immunol (1981) 0.80
Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series. Clin Exp Immunol (1981) 0.79
Gold nephropathy: serologic data suggesting an immune complex disease. Clin Exp Immunol (1976) 0.77
Platelet aggregation test with measles antigen in multiple sclerosis. Br Med J (1970) 0.76
The platelet aggregation test in group B arbovirus infections. J Hyg (Lond) (1970) 0.75
Polyarteritis presenting with thrombocytosis and palliated by plasma exchange. Postgrad Med J (1978) 0.75
Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis (1980) 4.10
Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins. J Cell Biol (1980) 2.50
Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21
Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol (1989) 2.15
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro. Clin Exp Immunol (1971) 1.60
Questionable specificity of lipid antigen in the Mycoplasma pneumoniae complement fixation test in patients with extrapulmonary manifestations. J Infect (1981) 1.58
Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction. Clin Exp Immunol (1969) 1.38
Wart-virus antibodies and the prognosis of wart disease. Lancet (1972) 1.36
Inhibition of IgG complex-induced platelet aggregation by antiglobulin-active cryoglobulin IgM components. Clin Exp Immunol (1973) 1.31
Determination of mumps and influenza antibodies by haemolysis-in-gel. Arch Virol (1976) 1.29
Detection and characterization of immune complexes by the platelet aggregation test. II. Circulating complexes. Clin Exp Immunol (1971) 1.26
Platelet aggregation and cryo-IgM in the study of hepatitis and immune complex states. Clin Exp Immunol (1973) 1.20
Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand (1988) 1.18
Association of serum lipids and obesity with cardiovascular mortality. Br Med J (1977) 1.17
Measles antibodies detected with various techniques in sera of patients with multiple sclerosis. Acta Neurol Scand (1971) 1.17
Disodium cromoglycate can inhibit virus-induced cytopathic effects in vitro. Br Med J (1977) 1.13
Letter: Negative complement-fixation tests as an immunopathological finding. Lancet (1974) 1.10
Platelet aggregation test in the study of hepatitis. Am J Dis Child (1972) 1.09
Mumps-specific immunoglobulin M and G antibodies in natural mumps infection as measured by enzyme-linked immunosorbent assay. J Med Virol (1981) 1.07
Metabolism of warfarin during methandrostenolone treatment. Ann Med Exp Biol Fenn (1965) 1.06
Aggregation of human blood platelets by immune complexes in the sedimentation pattern test. Scand J Haematol Suppl (1973) 1.06
Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol (1981) 1.06
Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J Infect Dis (1981) 1.04
Enzyme-linked immunosorbent assay for mumps and parainfluenza type 1 immunoglobulin G and immunoglobulin M antibodies. J Clin Microbiol (1980) 1.03
Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Scand (1993) 1.02
Enzyme-immunoassay in the detection of hepatitis B surface antigen. J Immunol Methods (1977) 1.00
Virus antibodies in serum specimens from patients with multiple sclerosis, from siblings, and matched controls. A final report. Acta Neurol Scand (1973) 0.99
Measles virus antibody in cerebrospinal fluids from patients with multiple sclerosis. Br Med J (1972) 0.98
Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients. J Med Virol (1981) 0.98
Q fever in Finland: clinical, immunological and epidemiological findings. Scand J Infect Dis (1981) 0.98
Role of platelets in immune-complex-induced aggregation of human blood platelets. Ann Med Exp Biol Fenn (1973) 0.97
Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years. J Med Virol (1984) 0.96
Association between influenza during pregnancy and childhood leukaemia. Br Med J (1973) 0.94
The red cell phenotype En(a-) and anti-Ena: serological and physicochemical aspects. Vox Sang (1969) 0.94
Circulating immune complexes, the concentration of serum IgA and the distribution of HLA antigens in IgA nephropathy. Nephron (1981) 0.93
Mumps vaccination in the Finnish defense forces. Am J Epidemiol (1968) 0.93
Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79. Br J Haematol (1982) 0.93
Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live vaccines. J Infect Dis (1978) 0.92
Circulating complexes in leprosy studied by the platelet aggregation test. The platelet aggregation test and its relation to the Rubino test and other sero-immunological parameters in 135 patients with leprosy. Clin Exp Immunol (1978) 0.91
Lack of measurable complement fixing antibodies against viral antigens. Acta Pathol Microbiol Scand B (1977) 0.90
Mk and Mg: some serological and physicochemical observations. Vox Sang (1969) 0.90
Detection of Au(1) antigen by immunodiffusion and platelet aggregation tests. Vox Sang (1971) 0.90
Platelets and 125I-labelled staphylococcal protein A in the detection of immune complexes in serum. J Clin Lab Immunol (1979) 0.89
Persistent mixed field polyagglutinability. Electrokinetic and serological aspects. Vox Sang (1971) 0.89
Diagnostic significance of indium-111 granulocyte scintigraphy in febrile patients. J Nucl Med (1987) 0.88
Transfusion thresholds in common elective surgical procedures in Finland. Vox Sang (2000) 0.85
Anti-HBe and subtypes of HBsAg among asymptomatic HBsAg carriers. Vox Sang (1979) 0.85
Platelet adhesiveness and ADP-induced platelet aggregation in exercise. Ann Med Exp Biol Fenn (1966) 0.84
Parainfluenza 1 (Sendai) antibodies and mumps vaccination. Ann Med Exp Biol Fenn (1967) 0.84
Transfusion policies in coronary artery bypass--a nationwide survey in Finland. Acta Anaesthesiol Scand (1998) 0.84
Characterization of material with epidermal growth factor immunoreactivity in human serum and platelets. J Clin Endocrinol Metab (1989) 0.83
Immune complex assays and stored normal human sera. J Immunol Methods (1983) 0.83
Glomerular electron-dense deposits and circulating immune complexes in patients with malignant tumours. Clin Nephrol (1980) 0.82
Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study. Eur Heart J (1994) 0.82
Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiol Scand (1995) 0.82
Detection of quinidine-specific antibodies with platelet 125I-labeled staphylococcal protein A test. Vox Sang (1980) 0.81
Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang (1994) 0.81
Effect of normal human serum on the binding of specific antibodies and platelet-unrelated immune complexes to human platelets. Scand J Immunol (1979) 0.81
Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients. J Infect Dis (1980) 0.81
Use of ELISA for measuring immunoconglutinins. J Immunol Methods (1978) 0.81
Porcine C1q and the solid-phase immunoassay of human immune complexes. J Immunol Methods (1982) 0.81
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group. Bone Marrow Transplant (1997) 0.81
Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood (1990) 0.80
Glucocorticoid receptors and glucocorticoid sensitivity of human leukemic cells. Int J Cancer (1980) 0.80
Cytomegalovirus antibody assay by platelet aggregation. Arch Gesamte Virusforsch (1970) 0.80
Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial. Transfusion (1991) 0.79
Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series. Clin Exp Immunol (1981) 0.79
EPO, red cells, and serum transferrin receptor in continuous and intermittent hypoxia. Med Sci Sports Exerc (2000) 0.79
Radial haemolysis in gel: a comparative study with Chikungunya, Japanese encephalitis and rubella viruses, representatives of three genera of Togaviridae family. Arch Virol (1980) 0.79
Coumarin anticogulant requirement in relation to serum cholesterol and triglyceride level. Acta Med Scand (1968) 0.79
Elevated serum immune complex levels in Pogosta disease, an acute alphavirus infection with rash and arthritis. J Clin Lab Immunol (1986) 0.79
The effect of HLA antibodies on platelet aggregation. Scand J Immunol (1977) 0.79
Differences in the effect of individual human sera on cell cultures. J Natl Cancer Inst (1965) 0.78
Serum lipoproteins in primary cell attachment and growth behaviour of cells on glass. Ann Med Exp Biol Fenn (1966) 0.78
The different effects of some methods of disaggregation on the electrophoretic mobility of the HeLa-cell. Ann Med Exp Biol Fenn (1965) 0.78
Clinical correlates of circulating immune complexes in patients with recent yersiniosis. J Infect Dis (1983) 0.78
Rheumatoid factor as an indicator of serum blocking activity and tumour recurrences in bladder tumours. Eur J Cancer (1976) 0.78
Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth (1991) 0.78
Factor XIII deficiency: a genetic study of two affected kindreds in Finland. Blood (1974) 0.78
Hemagglutination activity and morphology of influenza virus. Arch Environ Health (1970) 0.78
'Nonspecific' blocking of human ovarian carcinoma-associated cellular cytotoxicity in vitro. Scand J Immunol (1974) 0.78
Blood-group A and B determinants are located in different polyglycosyl peptides isolated from human erythrocytes of blood-group AB. Eur J Biochem (1981) 0.77
Immune responses to live attenuated and inactivated mumps virus vaccines in seronegative and seropositive young adult males. J Med Virol (1984) 0.77
Familial clustering of defective release of t-PA. Br J Haematol (1991) 0.77
Aggregation of human blood platelets by unrelated antigen-antibody reaction: sequence of reaction and role of complement. Ann Med Exp Biol Fenn (1973) 0.77
Antibodies to human coronavirus OC43 measured by radial haemolysis in gel. Scand J Infect Dis (1977) 0.77
Albumin, HES 120 and dextran 70 as adjuvants to red blood cell concentrates: a study on colloid osmotic pressure changes in vitro. Acta Anaesthesiol Scand (1991) 0.77
Cytoskeleton-dependent release of human platelet epidermal growth factor. Life Sci (1991) 0.76
Platelet activation during acute phase after multiple trauma. Ann Chir Gynaecol (1992) 0.76
Platelet aggregation test with measles antigen in multiple sclerosis. Br Med J (1970) 0.76